Search

everythinglearnresearchcommunity

for

Search:↓

Elderly patients with CCCA were all African American with low vitamin D, but no iron or zinc deficiencies, and no hormonal imbalances compared to younger patients.

The guidelines ensure accurate genetic testing and reporting for 21-hydroxylase deficiency.

A woman's hyperandrogenism was caused by a genetic mutation leading to non-classic adrenogenital syndrome.

Cronkhite-Canada syndrome may be more treatable and less severe than previously thought.

The mutated hairless gene causes hair loss by acting as a new type of corepressor affecting thyroid hormone receptors.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Diagnose and manage CCCA with thorough history, exams, and labs; treat with anti-inflammatory agents, stress reduction, and stopping harmful hair practices.

CA VI helps maintain pH balance and is important for various bodily functions.

Researchers found genetic mutations causing hypohidrotic ectodermal dysplasia in 88% of studied patients and identified new mutations and genetic variations affecting the disease.

Cepharanthine is a well-tolerated drug with multiple medical uses, including anti-inflammatory and anti-cancer properties.

Cronkhite-Canada syndrome is rare, has a poor prognosis, and requires early diagnosis and ongoing treatment.

Hair testing is crucial for forensic science and public health.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Variants in the CCDC47 gene are linked to trichohepatoneurodevelopmental syndrome.

Advancements in understanding, diagnosing, and managing congenital adrenal hyperplasia have improved treatment and long-term outcomes.

Dr. Bernard Cohen created a new system to classify hair loss using numbers and a detailed scalp map.

A genetic mutation in the EDA gene causes hypohidrotic ectodermal dysplasia in cats.

CE-PTG detects early hair follicle issues in balding areas, helping measure male hair loss.

Cepharanthine shows promise as a potential lung cancer treatment by effectively killing cancer cells.

A rare case of Cushing's syndrome and pheochromocytoma requires careful re-evaluation to avoid complications.

The hair erector muscle is involved in various skin conditions and disorders.

Cyproterone acetate combined with ethinyl estradiol significantly reduced hirsutism in women.

The fragrance cyclohexyl salicylate helps promote hair growth and increase hair stem cell numbers.

The document provided instructions for completing a CME exam on diagnosing and managing hair loss.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

CTHRC1 helps sweat glands recover by rebuilding nearby blood vessels.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

A child with eruptive vellus hair cysts showed some improvement with calcipotriene cream.